# A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

> **NCT01279785** · — · WITHDRAWN · sponsor: **Molecular Insight Pharmaceuticals, Inc.**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 123I-MIP-1072

## Key facts

- **NCT ID:** NCT01279785
- **Lead sponsor:** Molecular Insight Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Similar study to be completd once kit for new formulation becomes available.
- **Last updated:** 2015-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279785, "A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01279785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*